PHARMACOKINETICS OF HIGH-DOSE METHOTREXATE (NSC-740)

被引：0
|
作者：
STOLLER, RG
JACOBS, SA
DRAKE, JC
LUTZ, RJ
CHABNER, BA
机构：
[1] NIH, DIV RES SERV, BIOMED ENGN & INSTR BRANCH, BETHESDA, MD 20014 USA
[2] NCI, DIV CANC TREATMENT,LAB CHEM PHARMACOL,BLDG 10, RM6N119, BETHESDA, MD 20014 USA
来源：
CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT | 1975年 / 6卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：19 / 24
页数：6
相关论文
共 50 条
  • [21] MEMBRANE-TRANSPORT OF METHOTREXATE (NSC-740) IN HUMAN NEOPLASTIC-CELLS
    BENDER, RA
    CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (01): : 73 - 82
  • [22] COMBINATION CHEMOTHERAPY WITH CCNU (NSC-79037), HEXAMETHYLMELAMINE (NSC-13875) AND METHOTREXATE (NSC-740) IN ADVANCED BRONCHOGENIC CARCINOMA
    DIBELLA, NJ
    NELSON, RA
    NORGARD, MJ
    ONCOLOGY, 1975, 32 (02) : 82 - 85
  • [23] METHOTREXATE (NSC-740) WITH CITROVORUM FACTOR (NSC-3590) RESCUE, ALONE AND IN COMBINATION WITH CYCLOPHOSPHAMIDE (NSC-26271), IN OVARIAN CANCER
    BARLOW, JJ
    PIVER, MS
    CANCER TREATMENT REPORTS, 1976, 60 (05): : 527 - 533
  • [24] PHARMACOKINETICS OF ERYTHROCYTE METHOTREXATE AFTER HIGH-DOSE METHOTREXATE
    SCHALHORN, A
    SAUER, H
    WILMANNS, W
    STUPPPOUTOT, G
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 9 (01) : 65 - 69
  • [25] MEMBRANE-TRANSPORT OF METHOTREXATE (NSC-740) AND OTHER FOLATE COMPOUNDS - RELEVANCE TO RESCUE PROTOCOLS
    GOLDMAN, ID
    CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (01): : 63 - 72
  • [26] PHASE 2 TRIAL OF 5-FLUOROURACIL (NSC-19893), ADRIAMYCIN (NSC-123127), AND METHOTREXATE (NSC-740) IN LUNG ADENOCARCINOMA
    LOWITZ, BB
    CANCER TREATMENT REPORTS, 1976, 60 (05): : 623 - 624
  • [27] EVALUATION OF COMBINATION THERAPY WITH ADRIAMYCIN (NSC-123127) AND METHOTREXATE (NSC-740) IN PATIENTS WITH DISSEMINATED BREAST-CANCER
    AHMANN, DL
    EAGAN, RT
    BISEL, HF
    HAHN, RG
    OCONNELL, MJ
    EDMONSON, JH
    CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (02): : 335 - 338
  • [28] CLINICAL TRIAL OF METHOTREXATE (NSC-740) AND RADIATION-THERAPY FOR SQUAMOUS-CELL CARCINOMA OF LUNG
    TUCKER, RD
    SEALY, R
    VANWYK, C
    SOSKOLNE, CL
    LEROUX, PLM
    CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1973, 4 (02): : 157 - 158
  • [29] INTERMITTENT THERAPY WITH 6-MERCAPTOPURINE (NSC-755) AND METHOTREXATE (NSC-740) GIVEN INTRAVENOUSLY TO ADULTS WITH ACUTE LEUKEMIA
    ELLISON, RR
    SILVER, RT
    BLOM, J
    COOPER, T
    LEE, SL
    HAURANI, F
    HOLLAND, JF
    HOOGSTRATEN, B
    JACQUILLAT, C
    LEONE, LA
    LEVY, RN
    OBERFIELD, RA
    PAS, AT
    CANCER CHEMOTHERAPY REPORTS PART 1, 1972, 56 (04): : 535 - +
  • [30] COMBINATION CHEMOTHERAPY WITH 5-FLUOROURACIL (NSC-19893), METHOTREXATE (NSC-740), AND PREDNISOLONE (NSC-9900) (FAP PROTOCOL) FOR HEPATOMA
    UMSAWASDI, T
    CHAINUVATI, T
    HITANNANT, S
    NILPRABHASSORN, P
    VIRANUVATTI, V
    CANCER CHEMOTHERAPY REPORTS PART 1, 1975, 59 (06): : 1167 - 1169
12345